Avram Goldstein, MD Biography
- Title:
- Former Professor Emeritus of Pharmacology at Stanford University
- Position:
- Pro to the question "Should Marijuana Be a Medical Option?"
- Reasoning:
-
“We know that there are no extreme toxicity issues. It is a very safe drug, and therefore it would be perfectly safe medically to let the patient determine their own dose by the smoking route.”
Feb. 27, 1997
- Involvement and Affiliations:
-
- Professor Emeritus of Pharmacology, Stanford University
- Member, National Academy of Sciences
- Chairman, Section of Physiology and Pharmacology, National Academy of Sciences
- Member, Institute of Medicine
- Consultant, Receptron, Inc.
- Consultant, Neurobiological Technologies, Inc.
- Consultant and Founding Scientist, Affymax, N.V.
- Recipient, Franklin Medal
- Recipient, Nathan B.Eddy Award
- Recipient, Sollmann Award
- Director, Addiction Research Foundation, Stanford University, 1955-1989
- Served two terms on the National Advisory Council of the National Institute on Drug Abuse
- Former Honorary Professor, Beijing Medical University
- Former Honorary Professor, Institute of Materia Medica of the Academia Sinica
- Former Scientific Advisor, Syva Company
- Former Scientific Advisor, DNAX Research Institute
- Former Scientific Advisor, Abbott Laboratories
- Education:
-
- None found
- Other:
-
- Established the first methadone program in California, in San Jose
- Contributed important research findings on the use of methadone, LAAM, and naltrexone in the treatment of heroin addicts
- Played a key role in the development of rapid and efficient on-site urine tests for illicit drug use
- Born July 3, 1919 in New York City
- Died June 1, 2012